TTX

TTRATHERIX FPO [TTX]
Tetratherix Limited engages in biomaterial and regenerative medicine business in Australia and internationally. The company manufactures and commercialize medical device in the areas of bone regeneration, tissue spacing, and tissue healing applications through its Tetramatrix platform technology. Tetratherix Limited was incorporated in 2015 and is based in Alexandria, Australia.
Healthcare · ASX Small Cap
$6.5000 -1.5%

Updated 14 Jul 2026 · Signals refresh every scan

Get alerts when TTX triggers a new signal
Free watchlist with daily scans for 2,200+ ASX stocks
Track TTX — Free

Active Signals

Bullish Signals

  • MACD momentum is picking up steam
  • Trading above both moving averages — the trend is your friend here
  • Beating the Small Ords index — relative strength of 1.18, so it's outpacing the pack
  • Trading above the 200-day average — the long-term trend is on your side
  • Strong cash runway (13 quarters)
  • Very high P/S ratio (175.2x)
  • Strong revenue growth (+206%)
  • EPS estimates revised upward (+10pts)
  • Share Purchase Plan announced
  • CANSLIM S: Tight float (23%)
  • Sentiment is mixed — no strong consensus either way
  • Positive long-term momentum — up 33% over the past year
  • Revenue growing at +206% — the top line is moving in the right direction
  • The bigger volume days are the up days — volume-weighted momentum is positive (0.90%/day)
  • RBA hiking (-3pts)
  • Dilution risk: technical breakout with recent capital raise

Risk Signals

  • Piotroski F-Score weak (3/9, low-confidence approx)
  • Not enough chatter to gauge sentiment — defaulting to neutral
Ask Scout AI about TTX
"What's driving TTX today?" "How does TTX compare to peers?" "Key risks for TTX?"
3 free messages/day · Unlimited with Pro

Recent Catalysts

NONE Notification regarding unquoted securities - TTX
NONE Tutela Interim Study Results
NONE Application for quotation of securities - TTX
MEDIUM SPP Results
Announcement tone +3pts

Recent ASX Announcements

2026-07-01 Notification regarding unquoted securities - TTX
2026-06-22 Tutela Interim Study Results
2026-06-22 Application for quotation of securities - TTX
2026-06-21 SPP Results
2026-06-18 Application for quotation of securities - TTX

Key Metrics

$350.0M
Market Cap
14K
Avg Volume
1.4x
Vol Ratio
$3.09 — $7.50
52-Week Range
N/A
Short Interest
N/A
Cash Runway
-150.0%
ROE
N/A
Profit Margin

CANSLIM Analysis

FactorRatingDetail
CCurrent EPSfailEPS Growth: 0%
AAnnual EarningsfailCAGR: 0%
NNew Highs / Catalystsneutral
SSupply & DemandpassFloat: 23%
LLeader vs LaggardpassRS: 22
IInstitutional SponsorshipweakInst: 2%
MMarket DirectionneutralNeutral

Sector: Healthcare

109 tickers in this sector

View all Healthcare signals →
Related Tickers
ECS -20.0%MEM -12.5%NTI +12.5%VBS +11.4%BDX +11.0%
Compare:TTX vs ECSTTX vs MEMTTX vs NTI
Scout Pro — Deeper Analysis for TTX
Try Pro free for 30 days
Share this analysis

Track TTX and 2,200+ ASX stocks

Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and exit management for every ASX small cap.

Open Dashboard — Free Free Screener
No credit card required